Oscar Health (NYSE:OSCR) Posts Earnings Results, Misses Expectations By $0.07 EPS

Oscar Health (NYSE:OSCR) posted its quarterly earnings results on Tuesday. The company reported ($0.62) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.07), Zacks reports. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health updated its FY 2025 guidance to EPS.

Oscar Health Stock Down 8.9 %

Shares of NYSE OSCR opened at $15.27 on Wednesday. Oscar Health has a 52-week low of $12.84 and a 52-week high of $23.79. The firm has a 50 day moving average price of $15.20 and a two-hundred day moving average price of $16.85. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Insider Transactions at Oscar Health

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, bought 420,819 shares of the stock in a transaction on Tuesday, November 12th. The stock was acquired at an average cost of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the acquisition, the director now owns 5,452,081 shares in the company, valued at $74,584,468.08. This trade represents a 8.36 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Victoria Baltrus sold 8,078 shares of the stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $18.08, for a total value of $146,050.24. Following the transaction, the chief accounting officer now owns 146,036 shares in the company, valued at $2,640,330.88. The trade was a 5.24 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders purchased 1,055,478 shares of company stock worth $14,432,852 and sold 103,610 shares worth $1,847,519. 25.11% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Jefferies Financial Group assumed coverage on Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, Oscar Health has an average rating of “Hold” and an average target price of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.